Lymphohaematopoietic Growth Factors in Cancer Therapy II
Springer Berlin (Hersteller)
978-3-540-55953-5 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
Explores how recent advances in biotechnology, particularly in haematological and immunological research, may have considerable impact on cancerous tumour growth therapy. Both in vitro research and in vivo studies are discussed in this volume.
Prof. Dr. med. Roland Mertelsmann leitet als Ärztlicher Direktor die Abteilung Innere Medizin I, Hämatologie/Onkologie der Medizinischen Universitätsklinik und Poliklinik des Universitätsklinikums Freiburg.
Contents: Introduction and Overview.- Lymphopoietic Growth Factors: Pathophysiology of T-Cell Mediated Shock Induced by Bacterial Superantigens.- Natural Killer Cells and Interleukin-2-Activated Killer Cells.- Tumour Immunogenicity Induced by Exogenous Interleukins.- Cytokine Gene Therapy of Cancer.- Analysis of T-Cell Receptor Variability in Tumour Infiltrating Lymphocytes.- Clinical Studies with Interleukin-2: An Overview.- Clinical Trials with Local Administration of Lymphopoietic Growth Factors.- Clinical Trials with Interleukin-2. The Rome Experience. Haematopoietic Growth Factors: Lymphohaematopoietic Growth Factor Use in Lung Cancer Patients.- Clinical Trials with Haematopoietic Growth Factors and Peripheral Blood Stem Cells.
| Reihe/Serie | ESO Monographs |
|---|---|
| Zusatzinfo | 15 figs., 27 tabs. |
| Sprache | englisch |
| Gewicht | 622 g |
| Einbandart | gebunden |
| Schlagworte | ESO Monographs • Krebs (Krankheit) • Krebs (Krankheit) / Karzinom |
| ISBN-10 | 3-540-55953-1 / 3540559531 |
| ISBN-13 | 978-3-540-55953-5 / 9783540559535 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
